Article
A functional polymorphism in the HMGCR promoter affects transcriptional activity but not the risk for Alzheimer disease in Swedish populations.
Brain research - 16 Jul 2010
Keller Lina, Murphy Charlotte, Wang Hui-Xin, Fratiglioni Laura, Olin Maria, Gafvels Mats, Björkhem Ingemar, Graff Caroline, Meaney Steve
Abstract excerpt
Variations in genes associated with cholesterol homeostasis have been reported to modify the risk of developing Alzheimer disease (AD). To date there have been few investigations into variations in genes directly involved in cholesterol biosynthesis and AD. We investigated the influence of the -911C>A polymorphism (rs3761740) in the hydroxy-methyl-glutaryl CoA reductase (HMGCR) gene promoter on basal and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
